Galantamine: additional benefits to patients with Alzheimer's disease.
about
Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysisCholinergic modulation by opioid receptor ligands: potential application to Alzheimer's diseaseEfficacy study of galantamine in possible Alzheimer's disease with or without cerebrovascular disease and vascular dementia in Thai patients: a slow-titration regimenEvaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response.Predicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease.Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.Targeting acetylcholinesterase to treat neurodegeneration.The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory.Long-Term Efficacy of Galantamine in Alzheimer's Disease: The Okayama Galantamine Study (OGS).Pharmacokinetic and safety assessments of galantamine and risperidone after the two drugs are administered alone and together.Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects.
P2860
Q24805169-6C7FF374-C557-4FAF-9B85-8FDA3FBFD1C6Q26999066-61F75920-748D-40C7-9A15-49CA55B92924Q34655353-8DB8C19F-D032-4245-B819-D58FF0CF5DBFQ34762064-49DA97DA-29F0-4F03-A734-E8541B836E71Q35486605-424B0D6F-456F-420C-B01F-8835685FC58BQ36588166-3879E032-4A32-4B7E-BB7A-7CBE30BE8B96Q36709537-492F4ECB-6536-4289-8CEE-A17BE56CF3ADQ39016614-23EE2D7D-FB4D-41EA-874D-6E3845CBB15CQ41325631-A2B96019-8E09-4D12-AE90-D00D024B5551Q44237126-CC397E9B-7E4C-4DB1-B291-630CDF92ED8AQ46438866-693CFB62-6888-4ED6-9774-CDD871E472FA
P2860
Galantamine: additional benefits to patients with Alzheimer's disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Galantamine: additional benefits to patients with Alzheimer's disease.
@ast
Galantamine: additional benefits to patients with Alzheimer's disease.
@en
Galantamine: additional benefits to patients with Alzheimer's disease.
@nl
type
label
Galantamine: additional benefits to patients with Alzheimer's disease.
@ast
Galantamine: additional benefits to patients with Alzheimer's disease.
@en
Galantamine: additional benefits to patients with Alzheimer's disease.
@nl
prefLabel
Galantamine: additional benefits to patients with Alzheimer's disease.
@ast
Galantamine: additional benefits to patients with Alzheimer's disease.
@en
Galantamine: additional benefits to patients with Alzheimer's disease.
@nl
P356
P1476
Galantamine: additional benefits to patients with Alzheimer's disease.
@en
P2093
P356
10.1159/000051228
P478
11 Suppl 1
P577
2000-09-01T00:00:00Z